AcuraStem
PrivateLast Round
Early Stage
VC
Jun 22, 2026
Total Funding Raised
$26.73M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
AcuraStem is a biotechnology company that develops therapeutics for neurodegenerative diseases using its proprietary iNeuroRx® disease-modeling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcuraStem Comparables
Compare AcuraStem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuCyte | 88% | |
| Modulo Bio | 86% | |
| Quiver Bioscience | 84% | |
AcuraStem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jun 22, 2026 | ||||
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 10, 2026 | ||||
| Grant | Sep 3, 2024 | ||||
| Grant | Jan 30, 2024 | ||||
Grant | Dec 15, 2021 |
Key People
Founding team and executive leadership
AcuraStem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| Viva BioInnovator | Grant |
| Target ALS | Grant |
| California Institute for Regenerative Medicine | Grant |
| National Institute on Aging | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 157% MoM, reaching 1.5K.
- Jun 22, 2026
Raised an Early Stage VC round.
AcuraStem Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AcuraStem's valuation, stock price, and market status.